The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
 
Harm Westdorp
No Relationships to Disclose
 
Inge M. van Oort
Consulting or Advisory Role - Astellas Pharma; Bayer Health; Janssen-Cilag; Sanofi
Research Funding - Astellas Pharma; Bayer Health; Janssen-Cilag
 
Jeroen H.A. Creemers
No Relationships to Disclose
 
Gerty Schreibelt
No Relationships to Disclose
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; Bayer Health; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Merck Sharp & Dohme; Sanofi
 
Anna L. de Goede
No Relationships to Disclose
 
Christina Hulsbergen-Van De Kaa
No Relationships to Disclose
 
Carl G. Figdor
No Relationships to Disclose
 
Alfred Witjes
Consulting or Advisory Role - BioCancell; Cepheid; MEL Pharma; Nucleix; Spectrum Pharmaceuticals; taris
Research Funding - cepheid (Inst); Nucleix (Inst); taris (Inst)
 
Erik H.J.G. Aarntzen
No Relationships to Disclose
 
Roel D.M. Mus
No Relationships to Disclose
 
Martin Gotthardt
No Relationships to Disclose
 
Jelle O. Barentsz
No Relationships to Disclose
 
Jolanda De Vries
No Relationships to Disclose
 
Winald R. Gerritsen
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; CureVac; Janssen-Cilag; Merck Sharp & Dohme; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)